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assessed with WHO DTSQ. Use of InDuo also resulted in sig-
niﬁcantly higher rating of insulin therapy, lack of interference
with lifestyle and ease of injecting when away from home.
Seventy-nine percent patients preferred treatment with InDuo
rather than SVM, with convenience, ease of use, and accuracy
being major factors (p < 0.001). Other important features that
resulted in testing of BG more often with InDuo than with a
SVM included speciﬁc features like the 5-second BG analysis
(60%) and small blood sample requirement (55%). For InDuo
91% used BG memory several times a week (66% used doser
memory several times a week). Overall, the enrolled population
showed a signiﬁcant mean reduction of 0.54% in the A1C values
(p < 0.0001). Using combination device a large subset of patients
(32%) showed substantial increases in frequency of daily SMBG
monitoring (Mean 1 more reading/day). CONCLUSIONS: Use
of the InDuo was associated with improvements in patient treat-
ment satisfaction, which were reﬂected, in improved compliance
(more injections or blood tests per day) in a substantial portion
of the patients tested.
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OBJECTIVES: To examine admissions within the VA facility
among veterans with diabetes and the relationship between
number of admissions and type of antidiabetic therapy.
METHODS: Veterans with diabetes mellitus at a Texas Veterans
Health care System were selected by identifying those with an
ICD-9 code for diabetes from the outpatient ﬁle. Veterans who
received continuous care at the VA from FY 2000 to 2002 were
selected. Local Patient Treatment File and pharmacy ﬁle pro-
vided information on all VA admissions and prescription data.
A published method on attributing hospital utilization to dia-
betes based on ICD-9 codes and codes for diagnostic-related
groups from administrative databases were used. This method
classiﬁes admissions into 3 categories: clearly attributable to dia-
betes; probably attributable to diabetes; or not attributable to
diabetes. Type of medication therapy was deﬁned as the follow-
ing: oral therapy all 3 years; oral and insulin; insulin only; esca-
lating therapy; and other (i.e. insulin to oral or oral to no
medication). RESULTS: Of the 2285 veterans included in the
study, there were 1687 admissions at the VA facility over the 3-
year period. A total of 772 patients accounted for the admis-
sions. The mean length of stay per admission was 5.34 days (+/-
5.01). Of the admissions, 106 (6.4%) were clearly attributable
to diabetes; 578 (35.1%) were probably attributable to diabetes
and 964 (58.5%) were not attributable to diabetes. Comparisons
showed that mean rank for number of admissions for those on
oral therapy only was signiﬁcantly lower than the following:
both insulin and oral (Z = -5.43, p < 0.005); insulin only (Z =
-4.36, p < 0.005); escalating therapy (Z = -6.67, p < 0.005) and
other (Z = -7.01, p < 0.005). CONCLUSIONS: Approximately
40% of admissions among veterans with diabetes were either
clearly attributable or probably attributable to diabetes. Receiv-
ing oral therapy only was associated with fewer number of hos-
pital admissions than those on more intense therapy.
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OBJECTIVE: Glycemic control is a clinical outcome variable
often used in diabetes intervention research. Misconceptions
about A1C (glycosylated hemoglobin) and GHb (glycated hemo-
globin) measures can lead to the use of different glycemic control
measures within a study, threatening reliability and validity of
outcomes results. While A1C is the standard for long-term
glycemic control, the GHb measure may be more appropriate
among patients with hemoglobin variants like the sickle cell
factor and is sometimes used by clinicians who are aware that
their patient population has prevalence of these variants. GHb
measures are generally higher than A1Cs. The objective of this
study was to examine the impact on outcomes results of using
data from mixed (A1C or GHb) sites. METHODS: A conve-
nience sample of 183 patients from four patient care sites par-
ticipated in a cross-sectional survey measuring self-care
behaviors, diabetes history, and demographics. Glycemic control
data were gathered from patient charts and aggregated; one site
used GHb. Aggregated glycemic control data were analyzed with
other study variables. The GHb data were then converted to A1C
equivalents using a regression formula provided by the National
Glycohemoglobin Standardization Program (NGSP); analyses
were conducted again and compared. RESULTS: Mean glycemic
control for the sample with unconverted GHb readings was
8.40% (sd = 2.79); the mean for the A1C converted sample was
7.84% (sd = 1.89). Signiﬁcance of variable relationships varied
between the two, and the magnitude of relationship among 
correlated variables was greater among the unconverted GHb
sample. Mean glycemic control for both analyses revealed sta-
tistically signiﬁcant associations (p < 0.05) with readiness for all
diabetes self-care behaviors except vigorous exercise, but vari-
able associations among the group with unconverted GHbs were
stronger. CONCLUSIONS: If data within a study include dif-
ferent or non-standardized glycemic control measures, they
should be converted to be sure results reﬂect a standard variable.
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OBJECTIVES: The purpose of this study was to validate a dia-
betes resource consumption index (DRCI). METHODS: The
data for this study was collected from the Southern Arizona Vet-
erans Affairs Health care System. A random split study sample
was created from the computerized medical record of veterans
with diabetes. Model estimation was done on the ﬁrst sample (n
= 367) and validation using the other 50% of the sample (n =
367). A Fisher’s z-statistic was used to assess the degree of 
correspondence between the predicted and actual values
